Today

Agents

Chat

Arena

Discover

More

App

Axsome Therapeutics target price cut to $300 from $310 by BMO

AXSM•2026-11-03

BMO cut its target price for Axsome Therapeutics to $300 from $310.

Related News

N

Nuveen Churchill Direct Lending Q3 net investment income falls 12% to $18.78 million

NCDL•2026-11-03

Waystar Holding Corp.: Raymond James raises target price to $35 from $32

WAY•2026-11-03

Terrestrial Energy Inc: Wedbush initiates coverage with neutral rating; price target $4

IMSR•2026-11-03

FedEx Freight Holding Company Inc: Raymond James cuts target price to $162 from $165

FDXF•2026-11-03

Adeia slides after lowering annual forecast

ADEA•2026-11-03

Axsome Therapeutics target price cut to $300 from $310 by BMO - AXSM News | Rallies